In This SectionTexas Health Research & Education Institute
Disease or Condition
A study of patients who underwent bilateral stimulation of the STN using Libra/LibraXP Deep Brain Stimulation System as adjunctive treatment for reducing symptoms of advanced, levodopa-responsive Parkinson’s disease not adequately controlled w/medication
To assess the long term safety and efficacy of bilateral stimulation of the subthalamic nucleus (STN) using the Libra/Libra XP Deep Brain Stimulation System as an adjunctive treatment for reducing some of the symptoms of advanced, levodopa-responsive Parkinson’s disease that are not adequately controlled with medication.
Provide informed consent to participate in the study.
Patient completed and exited study C-04-01.
Patient remains implanted with the Libra/Libra XP™ Deep Brain Stimulation System.
Patient is willing to cooperate with the study requirements.
Patient who has not completed and exited study C-04-01 within four years of enrollment.